玻璃体切除治疗增殖性糖尿病视网膜病变-东南大学学报医学版

玻璃体切除治疗增殖性糖尿病视网膜病变

单位：1.东南大学附属中大医院眼科,江苏南京,210009； 2.日本名古屋Eye,Care,Nagoya,日本名古屋,450-0002； 3.日本国立名古屋病院眼科,日本名古屋,460-0001

分类号：R774.1, R779.6

出版年·卷·期（页码）：2003·22·第五期（326-327）

摘要：

目的:评价玻璃体切除术治疗增殖性糖尿病视网膜病变的效果.方法:93例(139只眼)增殖性糖尿病视网膜病变病例均行玻璃体切除术,术后平均随访(16.72±8.53)个月,对视力改善情况及手术失败的原因进行回顾性分析.结果:98只眼(70.50%)视力得到提高,术后视力明显好于术前(P<0.001);手术失败的主要原因是视网膜脱离和黄斑病变.结论:玻璃体切除术是治疗增殖性糖尿病视网膜病变的有效方法.

Objective To evaluate the effect of vitrectomy on proliferative diabetic retinopathy.Methods 93 cases (139 eyes) with proliferative diabetic retinopathy treated with vitrectomy were retrospectively analysed for their visual acuity and the factors causing the recurrence of PDR with a follow up of (16 72±8 53) months.Results The visual acuity after vitrectomy improved in 98 eyes (70 50%).The mean postoperative visual acuity was significantly better than the preoperative one( P <0.001).Retinal detachment and maculaopathy were the main reasons which led to failure of vitrectomy.Conclusion These results demonstrate that vitrectomy is an effective procedure in treating proliferative diabetic retinopathy.

参考文献：

[1] FERRIS F L Ⅲ, KASSOFF A, BRESNICK G H. New visual acuity charts for clinical research, 1982
[2] 罗成仁. 糖尿病视网膜病变:一项新世纪待开拓的紧迫课题. 中华眼底病杂志2000(3)
[3] SCHEPEN C L, AVILA M P, JALKH A E. Role of the vitreous in cystoid macular edema. 1984(Suppl). doi:10.1016/0039-6257(84)90232-7
[4] 张惠蓉. 近10年眼底病临床和基础研究回眸与展望. 中华眼科杂志2000(3)
[5] 栾洁, 李长生, 孙建宁. 玻璃体切割术结合眼内激光治疗增殖性糖尿病视网膜病变. 眼科新进展2002(3). doi:10.3969/j.issn.1003-5141.2002.03.017
[6] Stefansson E, NOVACK R L, HATCHEL D L. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion, 1990

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录